| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/04/2004 | WO2004001020A3 Methods and means to promote gut absorption |
| 03/04/2004 | WO2003106636A3 Novel methods for the delivery of polynucleotides to cells |
| 03/04/2004 | WO2003105908A9 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 03/04/2004 | WO2003105901A3 Use of aromatase inhibitors for the treatment of growth failure |
| 03/04/2004 | WO2003105677A3 Methods for treating viral diseases using modulators of amyloidogenic peptide aggregation |
| 03/04/2004 | WO2003103720A3 Compositions and methods for the use of bcl-2 transfected neurons |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003102019A3 Antisense modulation of sterol regulatory element-binding protein-1 expression |
| 03/04/2004 | WO2003101391A3 Therapeutic methods |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003097091A3 Glucan-based vaccines |
| 03/04/2004 | WO2003097086A3 Egf receptor antagonists in the treatment of gastric cancer |
| 03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |
| 03/04/2004 | WO2003087312A3 Inhibition of tumor growth via peroxiredoxin 3 |
| 03/04/2004 | WO2003084480A3 HAUSP-p53 INTERACTION AND USES THEREOF |
| 03/04/2004 | WO2003083485A3 Protein for use in hypoxia related conditions |
| 03/04/2004 | WO2003082216A9 Neuroprotectant methods, compositions, and screening methods thereof |
| 03/04/2004 | WO2003080657A3 Yeast pheromones for the treatment of infectious diseases |
| 03/04/2004 | WO2003080104A3 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 03/04/2004 | WO2003079993A3 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION |
| 03/04/2004 | WO2003074561A8 A method for treating allergic disease and asthma by recombinant adenovirus-and adeno-associated virus-mediated ifn-ϝ gene |
| 03/04/2004 | WO2003074555A3 Synthetic peptides from c. difficile |
| 03/04/2004 | WO2003073107A3 Neuropeptide receptor and uses thereof |
| 03/04/2004 | WO2003072787A3 Method for detection of leptin receptor ligands |
| 03/04/2004 | WO2003070972A9 RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/04/2004 | WO2003070896A3 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/04/2004 | WO2003070755A3 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier |
| 03/04/2004 | WO2003070229A3 Use of proteinase inhibitors in the treatment of autoimmune diseases |
| 03/04/2004 | WO2003068912A3 PSEUDOMONAS SYRINGAE HARPINS, HopPtoP AND HopPmaHPTO, AND THEIR USES |
| 03/04/2004 | WO2003068822A3 De-immunized (poly)peptide constructs |
| 03/04/2004 | WO2003062830A3 Fibronectin variants and screening methods |
| 03/04/2004 | WO2003060082A3 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/04/2004 | WO2003060076A3 Povidone-containing carriers for polypeptide growth factors |
| 03/04/2004 | WO2003059276A3 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 03/04/2004 | WO2003057720A3 Recovery of biofilament proteins from biological fluids |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003055442A3 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 03/04/2004 | WO2003053342A3 Antisense modulation of cd81 expression |
| 03/04/2004 | WO2003052094A3 Expression vector for the production of annexin v |
| 03/04/2004 | WO2003052072A3 Antisense modulation of estrogen receptor alpha expression |
| 03/04/2004 | WO2003051914A3 Ides, an igg-degrading enzyme of streptococcus pyogenes |
| 03/04/2004 | WO2003051912A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 03/04/2004 | WO2003050300A3 Diagnosis and treatment of cancer |
| 03/04/2004 | WO2003050254A3 Novel chimeric tnf ligands |
| 03/04/2004 | WO2003043574A3 Pharmaceutical compositions in particulate form |
| 03/04/2004 | WO2003039566A3 Methods of treatment in situ in the lungs of mammals |
| 03/04/2004 | WO2003039466A8 Method of treating estrogen responsive breast cancer |
| 03/04/2004 | WO2003039225A3 Antigen arrays comprising rankl for treatment of bone disease |
| 03/04/2004 | WO2003037928A3 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 03/04/2004 | WO2003037267A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/04/2004 | WO2003035683A3 Surfactant protein-d and atherosclerosis |
| 03/04/2004 | WO2003032904A3 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 03/04/2004 | WO2003026581A3 Pharmaceutical compositions and methods for treating cancer |
| 03/04/2004 | WO2003025007A3 Purified polypeptides involved in membrane biosynthesis |
| 03/04/2004 | WO2003017924A3 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
| 03/04/2004 | WO2003016348A3 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 03/04/2004 | WO2003012034A9 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/04/2004 | WO2003008544A3 Antisense modulation of transforming growth factor-beta 3 expression |
| 03/04/2004 | WO2003005961A3 A controlled release biodegradable gel matrix |
| 03/04/2004 | WO2003002136A3 Stable formulation of modified glp-1 |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2003000173A3 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 03/04/2004 | WO2002099092A3 Production of recombinant human lysosomal alpha-mannosidase |
| 03/04/2004 | WO2002095049A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 03/04/2004 | WO2002092762A3 Cytokine polypeptides |
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | WO2002078640A3 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 03/04/2004 | WO2002073373A3 Ensemble-based strategy for the design of protein pharmaceuticals |
| 03/04/2004 | WO2002048310A9 Methods and compositions for diagnosing and treating rheumatoid arthritis |
| 03/04/2004 | WO2002044424A9 Compositions, methods, apparatus and products comprising a stathmin/oncoprotein 18 sequence for detecting and treating cancer |
| 03/04/2004 | WO2002036158A8 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 03/04/2004 | WO2002026931A3 71 human secreted proteins |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002014352A9 Therapeutic compounds for ovarian cancer |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | WO2001057276A9 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow |
| 03/04/2004 | US20040045042 Controlling oocytes, blocking fertility; prevention reproduction |
| 03/04/2004 | US20040044405 Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same |
| 03/04/2004 | US20040044272 Personal condition management system |
| 03/04/2004 | US20040044191 Comprises nucleotide sequences coding signal sequence polypeptides for diagnosis, prevention and treatment of cell proliferative, cardiovascular and infectious disorders |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044186 Comprises natural killer cell stimulatory factor protein (NKSF) inducing interferons and treating tumors, viral infection and blood disorders |
| 03/04/2004 | US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases |
| 03/04/2004 | US20040044183 Peptide inhibitors of HIV entry |
| 03/04/2004 | US20040044177 Somatostatin analogue as peptide and chelating group covalently linked to N-terminal free amino group of peptide, wherein analogue carries 1-naphthylalanine or 3-benzothienylalanine residue in 3-position; diagnosis |
| 03/04/2004 | US20040044077 Agents for inhibiting or restoring skin damage caused by drying and method for evaluating the same |
| 03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/04/2004 | US20040044035 Antiallergens; rhinitis |
| 03/04/2004 | US20040044001 Use of II-1 inhibitors for treating II-1 mediated diseases |
| 03/04/2004 | US20040043977 Alzheimer's disease |
| 03/04/2004 | US20040043971 Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
| 03/04/2004 | US20040043957 Antisense modulation of urokinase plasminogen activator expression |
| 03/04/2004 | US20040043956 Hybrid nucleic acid; skin disorders; antiinflammatory agents |
| 03/04/2004 | US20040043950 Oligonucleotide antibodies; anticancer agents; measurement gene expression in sample; calibration |
| 03/04/2004 | US20040043948 Hybrid nucleic acids |
| 03/04/2004 | US20040043941 Antiinflamamtory agents; autoimmune disease; anticancer agents |
| 03/04/2004 | US20040043938 Combination therapy for estrogen-dependent disorders |
| 03/04/2004 | US20040043937 Antiinflammatory agents; osteoporosis; thrombosis; grafting of organs |
| 03/04/2004 | US20040043936 Antiproliferative and antiviral proteins and peptides |
| 03/04/2004 | US20040043934 Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes |